Hepatitis C virus treatment is often restricted in Medicaid patients. This analysis evaluates the clinical and cost impacts of treating all Medicaid patients versus the current status quo.
Rachel Beckerman, PhD
Advertisement
Articles by Rachel Beckerman, PhD
Advertisement
Latest Updated Articles
- Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact
Published: February 16th 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Shifts in Colorectal Cancer Screening Trends After COVID-19
2
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
3
Challenges, Opportunities in Implementing the MDPP: Melanie T. Turk, PhD, RN
4
3 New Study Findings to Look Out for at Menopause Society 2025
5
